These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34212195)

  • 41. Pulsatile, nyctohemeral and entropic characteristics of GH secretion in adult GH-deficient patients: selectively decreased pulsatile release and increased secretory disorderliness with preservation of diurnal timing and gender distinctions.
    Roelfsema F; Biermasz NR; Veldhuis JD
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):79-87. PubMed ID: 11849250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men.
    Iranmanesh A; Lawson D; Veldhuis JD
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2172-9. PubMed ID: 22472562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
    Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
    Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
    Lo J; You SM; Canavan B; Liebau J; Beltrani G; Koutkia P; Hemphill L; Lee H; Grinspoon S
    JAMA; 2008 Aug; 300(5):509-19. PubMed ID: 18677023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study.
    Hoyos CM; Killick R; Keenan DM; Baxter RC; Veldhuis JD; Liu PY
    Sleep; 2014 Apr; 37(4):733-41. PubMed ID: 24899762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations.
    Ho KY; Evans WS; Blizzard RM; Veldhuis JD; Merriam GR; Samojlik E; Furlanetto R; Rogol AD; Kaiser DL; Thorner MO
    J Clin Endocrinol Metab; 1987 Jan; 64(1):51-8. PubMed ID: 3782436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
    Cheetham TD; Clayton KL; Taylor AM; Holly J; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):515-22. PubMed ID: 8187319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD; Norman C; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4753-60. PubMed ID: 22990092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Iranmanesh A; Veldhuis JD; Bouillon R
    Clin Endocrinol (Oxf); 2002 May; 56(5):655-69. PubMed ID: 12030918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.
    Chapman IM; Bach MA; Van Cauter E; Farmer M; Krupa D; Taylor AM; Schilling LM; Cole KY; Skiles EH; Pezzoli SS; Hartman ML; Veldhuis JD; Gormley GJ; Thorner MO
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4249-57. PubMed ID: 8954023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.
    Copinschi G; Van Onderbergen A; L'Hermite-Balériaux M; Mendel CM; Caufriez A; Leproult R; Bolognese JA; De Smet M; Thorner MO; Van Cauter E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2776-82. PubMed ID: 8768828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age and secretagogue type jointly determine dynamic growth hormone responses to exogenous insulin-like growth factor-negative feedback in healthy men.
    Veldhuis JD; Weltman JY; Weltman AL; Iranmanesh A; Muller EE; Bowers CY
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5542-8. PubMed ID: 15531509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulsatile growth hormone secretion in older persons is enhanced by fasting without relationship to sleep stages.
    Hartman ML; Pezzoli SS; Hellmann PJ; Suratt PM; Thorner MO
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2694-701. PubMed ID: 8675598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The beneficial effects of growth hormone replacement therapy on elderly men].
    Kozakowski J; Adamkiewicz M; Krassowski J; Zgliczyński S
    Pol Merkur Lekarski; 1999 Mar; 6(33):131-4. PubMed ID: 10365596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of transdermal testosterone gel or an aromatase inhibitor on serum concentration and pulsatility of growth hormone in older men with age-related low testosterone.
    Dias JP; Veldhuis JD; Carlson O; Shardell M; Chia CW; Melvin D; Egan JM; Basaria S
    Metabolism; 2017 Apr; 69():143-147. PubMed ID: 28285644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men.
    Muniyappa R; Sorkin JD; Veldhuis JD; Harman SM; Münzer T; Bhasin S; Blackman MR
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E769-75. PubMed ID: 17550998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term testosterone supplementation relieves growth hormone autonegative feedback in men.
    Veldhuis JD; Evans WS; Iranmanesh A; Weltman AL; Bowers CY
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1285-90. PubMed ID: 15001624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.